Cargando…
Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer
BACKGROUND: To rummage autophagy-related prognostic, diagnostic, and therapeutic biomarkers in cervical cancer (CC). METHODS: The RNA-sequence and clinical information were from the TCGA and GTEx databases. We operated Cox regression to determine signatures related to overall survival (OS) and recur...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268251/ https://www.ncbi.nlm.nih.gov/pubmed/34238288 http://dx.doi.org/10.1186/s12935-021-02073-w |
_version_ | 1783720315773255680 |
---|---|
author | Meng, Dan Jin, Hua Zhang, Xing Yan, Wenjing Xia, Qianqian Shen, Siyuan Xie, Shuqian Cui, Mengjing Ding, Bo Gu, Yun Wang, Shizhi |
author_facet | Meng, Dan Jin, Hua Zhang, Xing Yan, Wenjing Xia, Qianqian Shen, Siyuan Xie, Shuqian Cui, Mengjing Ding, Bo Gu, Yun Wang, Shizhi |
author_sort | Meng, Dan |
collection | PubMed |
description | BACKGROUND: To rummage autophagy-related prognostic, diagnostic, and therapeutic biomarkers in cervical cancer (CC). METHODS: The RNA-sequence and clinical information were from the TCGA and GTEx databases. We operated Cox regression to determine signatures related to overall survival (OS) and recurrence-free survival (RFS) respectively. The diagnostic and therapeutic effectiveness of prognostic biomarkers were further explored. RESULTS: We identified nine (VAMP7, MTMR14, ATG4D, KLHL24, TP73, NAMPT, CD46, HGS, ATG4C) and three risk signatures (SERPINA1, HSPB8, SUPT20H) with prognostic values for OS and RFS respectively. Six risk signatures (ATG4C, ATG4D, CD46, TP73, SERPINA1, HSPB8) were selected for qPCR. We screened five prognostic signatures(ATG4C, CD46, HSPB8, MTMR14, NAMPT) with diagnostic function through the GEO database. Correlation between our models and treatment targets certificated the prognostic score provided a reference for precision medicine. CONCLUSIONS: We constructed OS and RFS prognostic models in CC. Autophagy-related risk signatures might serve as diagnostic and therapeutic biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02073-w. |
format | Online Article Text |
id | pubmed-8268251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82682512021-07-09 Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer Meng, Dan Jin, Hua Zhang, Xing Yan, Wenjing Xia, Qianqian Shen, Siyuan Xie, Shuqian Cui, Mengjing Ding, Bo Gu, Yun Wang, Shizhi Cancer Cell Int Primary Research BACKGROUND: To rummage autophagy-related prognostic, diagnostic, and therapeutic biomarkers in cervical cancer (CC). METHODS: The RNA-sequence and clinical information were from the TCGA and GTEx databases. We operated Cox regression to determine signatures related to overall survival (OS) and recurrence-free survival (RFS) respectively. The diagnostic and therapeutic effectiveness of prognostic biomarkers were further explored. RESULTS: We identified nine (VAMP7, MTMR14, ATG4D, KLHL24, TP73, NAMPT, CD46, HGS, ATG4C) and three risk signatures (SERPINA1, HSPB8, SUPT20H) with prognostic values for OS and RFS respectively. Six risk signatures (ATG4C, ATG4D, CD46, TP73, SERPINA1, HSPB8) were selected for qPCR. We screened five prognostic signatures(ATG4C, CD46, HSPB8, MTMR14, NAMPT) with diagnostic function through the GEO database. Correlation between our models and treatment targets certificated the prognostic score provided a reference for precision medicine. CONCLUSIONS: We constructed OS and RFS prognostic models in CC. Autophagy-related risk signatures might serve as diagnostic and therapeutic biomarkers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02073-w. BioMed Central 2021-07-08 /pmc/articles/PMC8268251/ /pubmed/34238288 http://dx.doi.org/10.1186/s12935-021-02073-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Meng, Dan Jin, Hua Zhang, Xing Yan, Wenjing Xia, Qianqian Shen, Siyuan Xie, Shuqian Cui, Mengjing Ding, Bo Gu, Yun Wang, Shizhi Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title | Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title_full | Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title_fullStr | Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title_full_unstemmed | Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title_short | Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
title_sort | identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268251/ https://www.ncbi.nlm.nih.gov/pubmed/34238288 http://dx.doi.org/10.1186/s12935-021-02073-w |
work_keys_str_mv | AT mengdan identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT jinhua identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT zhangxing identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT yanwenjing identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT xiaqianqian identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT shensiyuan identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT xieshuqian identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT cuimengjing identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT dingbo identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT guyun identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer AT wangshizhi identificationofautophagyrelatedrisksignaturesfortheprognosisdiagnosisandtargetedtherapyincervicalcancer |